He writes:

And it's just what many of us have wondered over the years, what the various companies that Pfizer has acquired might have done if they'd just been left alone. Could they possibly have been less productive than they were after they were absorbed?

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.